nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—ABCB1—peripheral nervous system neoplasm	0.268	1	CbGaD
Propranolol—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.058	0.104	CbGbCtD
Propranolol—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0499	0.0894	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0464	0.0831	CbGbCtD
Propranolol—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0464	0.0831	CbGbCtD
Propranolol—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0365	0.0653	CbGbCtD
Propranolol—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0348	0.0624	CbGbCtD
Propranolol—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0279	0.0499	CbGbCtD
Propranolol—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0244	0.0437	CbGbCtD
Propranolol—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0244	0.0437	CbGbCtD
Propranolol—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0223	0.0399	CbGbCtD
Propranolol—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0213	0.0382	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0213	0.0382	CbGbCtD
Propranolol—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0169	0.0303	CbGbCtD
Propranolol—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.016	0.0286	CbGbCtD
Propranolol—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0147	0.0262	CbGbCtD
Propranolol—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0146	0.0262	CbGbCtD
Propranolol—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0136	0.0243	CbGbCtD
Propranolol—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0109	0.0195	CbGbCtD
Propranolol—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0104	0.0186	CbGbCtD
Propranolol—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00971	0.0174	CbGbCtD
Propranolol—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00954	0.0171	CbGbCtD
Propranolol—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00651	0.0116	CbGbCtD
Propranolol—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00624	0.0112	CbGbCtD
Propranolol—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00613	0.011	CbGbCtD
Propranolol—HTR1B—dura mater—peripheral nervous system neoplasm	0.00608	0.405	CbGeAlD
Propranolol—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00571	0.0102	CbGbCtD
Propranolol—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0039	0.00698	CbGbCtD
Propranolol—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.00261	0.174	CbGeAlD
Propranolol—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00186	0.124	CbGeAlD
Propranolol—HTR1B—ganglion—peripheral nervous system neoplasm	0.000942	0.0628	CbGeAlD
Propranolol—HTR1A—ganglion—peripheral nervous system neoplasm	0.00076	0.0507	CbGeAlD
Propranolol—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	0.00064	0.0427	CbGeAlD
Propranolol—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.000463	0.0308	CbGeAlD
Propranolol—HTR1B—brainstem—peripheral nervous system neoplasm	0.00041	0.0273	CbGeAlD
Propranolol—HTR1A—brainstem—peripheral nervous system neoplasm	0.00033	0.022	CbGeAlD
Propranolol—CYP1A1—parotid gland—peripheral nervous system neoplasm	0.000265	0.0177	CbGeAlD
Propranolol—Atenolol—ABCB1—peripheral nervous system neoplasm	0.000254	0.264	CrCbGaD
Propranolol—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000242	0.00155	CcSEcCtD
Propranolol—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.00152	CcSEcCtD
Propranolol—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.000236	0.00151	CcSEcCtD
Propranolol—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.00151	CcSEcCtD
Propranolol—Acebutolol—ABCB1—peripheral nervous system neoplasm	0.000234	0.243	CrCbGaD
Propranolol—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00149	CcSEcCtD
Propranolol—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.00149	CcSEcCtD
Propranolol—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000233	0.00149	CcSEcCtD
Propranolol—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000231	0.00147	CcSEcCtD
Propranolol—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000231	0.00147	CcSEcCtD
Propranolol—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000231	0.00147	CcSEcCtD
Propranolol—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000231	0.00147	CcSEcCtD
Propranolol—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000229	0.00146	CcSEcCtD
Propranolol—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000228	0.00146	CcSEcCtD
Propranolol—Infection—Vincristine—peripheral nervous system neoplasm	0.000227	0.00145	CcSEcCtD
Propranolol—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000227	0.00145	CcSEcCtD
Propranolol—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000225	0.00144	CcSEcCtD
Propranolol—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000225	0.00144	CcSEcCtD
Propranolol—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000225	0.00143	CcSEcCtD
Propranolol—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000224	0.00143	CcSEcCtD
Propranolol—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000223	0.00142	CcSEcCtD
Propranolol—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000222	0.00142	CcSEcCtD
Propranolol—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000221	0.00141	CcSEcCtD
Propranolol—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000219	0.0014	CcSEcCtD
Propranolol—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000219	0.0014	CcSEcCtD
Propranolol—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.0014	CcSEcCtD
Propranolol—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000219	0.0014	CcSEcCtD
Propranolol—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00138	CcSEcCtD
Propranolol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000216	0.00138	CcSEcCtD
Propranolol—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00138	CcSEcCtD
Propranolol—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00138	CcSEcCtD
Propranolol—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000215	0.00137	CcSEcCtD
Propranolol—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.00137	CcSEcCtD
Propranolol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000215	0.00137	CcSEcCtD
Propranolol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000215	0.00137	CcSEcCtD
Propranolol—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00136	CcSEcCtD
Propranolol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.00135	CcSEcCtD
Propranolol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000212	0.00135	CcSEcCtD
Propranolol—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.00135	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00021	0.00134	CcSEcCtD
Propranolol—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00021	0.00134	CcSEcCtD
Propranolol—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000209	0.00134	CcSEcCtD
Propranolol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000209	0.00133	CcSEcCtD
Propranolol—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000208	0.00133	CcSEcCtD
Propranolol—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00132	CcSEcCtD
Propranolol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000207	0.00132	CcSEcCtD
Propranolol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000207	0.00132	CcSEcCtD
Propranolol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000207	0.00132	CcSEcCtD
Propranolol—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000207	0.00132	CcSEcCtD
Propranolol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000206	0.00131	CcSEcCtD
Propranolol—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.00131	CcSEcCtD
Propranolol—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.00131	CcSEcCtD
Propranolol—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000204	0.0013	CcSEcCtD
Propranolol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.0013	CcSEcCtD
Propranolol—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.0013	CcSEcCtD
Propranolol—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.0013	CcSEcCtD
Propranolol—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000203	0.00129	CcSEcCtD
Propranolol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000203	0.00129	CcSEcCtD
Propranolol—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000202	0.00129	CcSEcCtD
Propranolol—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.00129	CcSEcCtD
Propranolol—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00128	CcSEcCtD
Propranolol—Infection—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00128	CcSEcCtD
Propranolol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000201	0.00128	CcSEcCtD
Propranolol—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00128	CcSEcCtD
Propranolol—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00128	CcSEcCtD
Propranolol—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00128	CcSEcCtD
Propranolol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000199	0.00127	CcSEcCtD
Propranolol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000199	0.00127	CcSEcCtD
Propranolol—Rash—Topotecan—peripheral nervous system neoplasm	0.000199	0.00127	CcSEcCtD
Propranolol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000199	0.00127	CcSEcCtD
Propranolol—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000199	0.00127	CcSEcCtD
Propranolol—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000199	0.00127	CcSEcCtD
Propranolol—Cough—Etoposide—peripheral nervous system neoplasm	0.000198	0.00127	CcSEcCtD
Propranolol—Metoprolol—ABCB1—peripheral nervous system neoplasm	0.000198	0.205	CrCbGaD
Propranolol—Rash—Tretinoin—peripheral nervous system neoplasm	0.000198	0.00126	CcSEcCtD
Propranolol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000198	0.00126	CcSEcCtD
Propranolol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000198	0.00126	CcSEcCtD
Propranolol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000197	0.00126	CcSEcCtD
Propranolol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000197	0.00126	CcSEcCtD
Propranolol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000197	0.00126	CcSEcCtD
Propranolol—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000197	0.00126	CcSEcCtD
Propranolol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000197	0.00126	CcSEcCtD
Propranolol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000197	0.00126	CcSEcCtD
Propranolol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000196	0.00125	CcSEcCtD
Propranolol—Pain—Vincristine—peripheral nervous system neoplasm	0.000196	0.00125	CcSEcCtD
Propranolol—Rash—Melphalan—peripheral nervous system neoplasm	0.000195	0.00125	CcSEcCtD
Propranolol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000195	0.00124	CcSEcCtD
Propranolol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.00124	CcSEcCtD
Propranolol—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00123	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000192	0.00123	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00122	CcSEcCtD
Propranolol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000189	0.00121	CcSEcCtD
Propranolol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.00121	CcSEcCtD
Propranolol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.0012	CcSEcCtD
Propranolol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.0012	CcSEcCtD
Propranolol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000188	0.0012	CcSEcCtD
Propranolol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000187	0.0012	CcSEcCtD
Propranolol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000186	0.00119	CcSEcCtD
Propranolol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000186	0.00119	CcSEcCtD
Propranolol—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.00119	CcSEcCtD
Propranolol—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000185	0.00118	CcSEcCtD
Propranolol—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00118	CcSEcCtD
Propranolol—Infection—Etoposide—peripheral nervous system neoplasm	0.000184	0.00118	CcSEcCtD
Propranolol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000184	0.00117	CcSEcCtD
Propranolol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000184	0.00117	CcSEcCtD
Propranolol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000182	0.00116	CcSEcCtD
Propranolol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000181	0.00116	CcSEcCtD
Propranolol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000181	0.00116	CcSEcCtD
Propranolol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00018	0.00115	CcSEcCtD
Propranolol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00018	0.00115	CcSEcCtD
Propranolol—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000179	0.012	CbGeAlD
Propranolol—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00113	CcSEcCtD
Propranolol—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000176	0.00112	CcSEcCtD
Propranolol—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00112	CcSEcCtD
Propranolol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000175	0.00112	CcSEcCtD
Propranolol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.00112	CcSEcCtD
Propranolol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000175	0.00112	CcSEcCtD
Propranolol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000173	0.00111	CcSEcCtD
Propranolol—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00109	CcSEcCtD
Propranolol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.00109	CcSEcCtD
Propranolol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000169	0.00108	CcSEcCtD
Propranolol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000167	0.00106	CcSEcCtD
Propranolol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000165	0.00106	CcSEcCtD
Propranolol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000165	0.00105	CcSEcCtD
Propranolol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000164	0.00105	CcSEcCtD
Propranolol—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000163	0.00104	CcSEcCtD
Propranolol—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000163	0.00104	CcSEcCtD
Propranolol—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000163	0.0109	CbGeAlD
Propranolol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000163	0.00104	CcSEcCtD
Propranolol—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00104	CcSEcCtD
Propranolol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.00104	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00103	CcSEcCtD
Propranolol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000162	0.00103	CcSEcCtD
Propranolol—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000161	0.00103	CcSEcCtD
Propranolol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00016	0.00102	CcSEcCtD
Propranolol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00016	0.00102	CcSEcCtD
Propranolol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00016	0.00102	CcSEcCtD
Propranolol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000159	0.00101	CcSEcCtD
Propranolol—Pain—Etoposide—peripheral nervous system neoplasm	0.000159	0.00101	CcSEcCtD
Propranolol—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.00101	CcSEcCtD
Propranolol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.001	CcSEcCtD
Propranolol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000157	0.001	CcSEcCtD
Propranolol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000152	0.000972	CcSEcCtD
Propranolol—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000971	CcSEcCtD
Propranolol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000152	0.000968	CcSEcCtD
Propranolol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000151	0.000967	CcSEcCtD
Propranolol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000964	CcSEcCtD
Propranolol—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000963	CcSEcCtD
Propranolol—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000963	CcSEcCtD
Propranolol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.000956	CcSEcCtD
Propranolol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.000956	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000955	CcSEcCtD
Propranolol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000952	CcSEcCtD
Propranolol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000951	CcSEcCtD
Propranolol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000147	0.000941	CcSEcCtD
Propranolol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000147	0.000936	CcSEcCtD
Propranolol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000147	0.000936	CcSEcCtD
Propranolol—Propafenone—ABCB1—peripheral nervous system neoplasm	0.000146	0.151	CrCbGaD
Propranolol—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000146	0.00972	CbGeAlD
Propranolol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000146	0.000929	CcSEcCtD
Propranolol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000145	0.000927	CcSEcCtD
Propranolol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000927	CcSEcCtD
Propranolol—Rash—Vincristine—peripheral nervous system neoplasm	0.000144	0.000922	CcSEcCtD
Propranolol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000144	0.000921	CcSEcCtD
Propranolol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.000901	CcSEcCtD
Propranolol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000141	0.0009	CcSEcCtD
Propranolol—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000899	CcSEcCtD
Propranolol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000139	0.000884	CcSEcCtD
Propranolol—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000883	CcSEcCtD
Propranolol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00088	CcSEcCtD
Propranolol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000137	0.000872	CcSEcCtD
Propranolol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000136	0.000868	CcSEcCtD
Propranolol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000867	CcSEcCtD
Propranolol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000858	CcSEcCtD
Propranolol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000133	0.00085	CcSEcCtD
Propranolol—Carvedilol—ABCB1—peripheral nervous system neoplasm	0.000131	0.136	CrCbGaD
Propranolol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000833	CcSEcCtD
Propranolol—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000826	CcSEcCtD
Propranolol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000822	CcSEcCtD
Propranolol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000818	CcSEcCtD
Propranolol—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000817	CcSEcCtD
Propranolol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000815	CcSEcCtD
Propranolol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000814	CcSEcCtD
Propranolol—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000813	CcSEcCtD
Propranolol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000127	0.00081	CcSEcCtD
Propranolol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000802	CcSEcCtD
Propranolol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000123	0.000783	CcSEcCtD
Propranolol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000768	CcSEcCtD
Propranolol—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000764	CcSEcCtD
Propranolol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000757	CcSEcCtD
Propranolol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000118	0.000753	CcSEcCtD
Propranolol—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000752	CcSEcCtD
Propranolol—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000747	CcSEcCtD
Propranolol—Rash—Etoposide—peripheral nervous system neoplasm	0.000117	0.000747	CcSEcCtD
Propranolol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000117	0.000746	CcSEcCtD
Propranolol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000731	CcSEcCtD
Propranolol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00071	CcSEcCtD
Propranolol—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000705	CcSEcCtD
Propranolol—Nausea—Etoposide—peripheral nervous system neoplasm	0.00011	0.000703	CcSEcCtD
Propranolol—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000692	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000688	CcSEcCtD
Propranolol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000676	CcSEcCtD
Propranolol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000664	CcSEcCtD
Propranolol—Infection—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000659	CcSEcCtD
Propranolol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000657	CcSEcCtD
Propranolol—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000652	CcSEcCtD
Propranolol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000651	CcSEcCtD
Propranolol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000645	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.000636	CcSEcCtD
Propranolol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.62e-05	0.000614	CcSEcCtD
Propranolol—Infection—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.00061	CcSEcCtD
Propranolol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.43e-05	0.000602	CcSEcCtD
Propranolol—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.4e-05	0.0006	CcSEcCtD
Propranolol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000597	CcSEcCtD
Propranolol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.000596	CcSEcCtD
Propranolol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.000592	CcSEcCtD
Propranolol—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.24e-05	0.00059	CcSEcCtD
Propranolol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.15e-05	0.000584	CcSEcCtD
Propranolol—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.000577	CcSEcCtD
Propranolol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000573	CcSEcCtD
Propranolol—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.96e-05	0.000572	CcSEcCtD
Propranolol—Pain—Epirubicin—peripheral nervous system neoplasm	8.89e-05	0.000568	CcSEcCtD
Propranolol—Constipation—Epirubicin—peripheral nervous system neoplasm	8.89e-05	0.000568	CcSEcCtD
Propranolol—CYP2D6—cerebellum—peripheral nervous system neoplasm	8.85e-05	0.0059	CbGeAlD
Propranolol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.7e-05	0.000555	CcSEcCtD
Propranolol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.000551	CcSEcCtD
Propranolol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000548	CcSEcCtD
Propranolol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.55e-05	0.000546	CcSEcCtD
Propranolol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.5e-05	0.000543	CcSEcCtD
Propranolol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.47e-05	0.000541	CcSEcCtD
Propranolol—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000534	CcSEcCtD
Propranolol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.00053	CcSEcCtD
Propranolol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.000529	CcSEcCtD
Propranolol—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.000527	CcSEcCtD
Propranolol—Pain—Doxorubicin—peripheral nervous system neoplasm	8.23e-05	0.000525	CcSEcCtD
Propranolol—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.23e-05	0.000525	CcSEcCtD
Propranolol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.22e-05	0.000525	CcSEcCtD
Propranolol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.22e-05	0.000525	CcSEcCtD
Propranolol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000502	CcSEcCtD
Propranolol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.66e-05	0.000489	CcSEcCtD
Propranolol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.000488	CcSEcCtD
Propranolol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.6e-05	0.000485	CcSEcCtD
Propranolol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.6e-05	0.000485	CcSEcCtD
Propranolol—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000476	CcSEcCtD
Propranolol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.11e-05	0.000454	CcSEcCtD
Propranolol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000452	CcSEcCtD
Propranolol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000441	CcSEcCtD
Propranolol—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.87e-05	0.000439	CcSEcCtD
Propranolol—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000422	CcSEcCtD
Propranolol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.00042	CcSEcCtD
Propranolol—Rash—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.000418	CcSEcCtD
Propranolol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.000418	CcSEcCtD
Propranolol—ABCB1—cerebellum—peripheral nervous system neoplasm	6.36e-05	0.00424	CbGeAlD
Propranolol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000406	CcSEcCtD
Propranolol—Nausea—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000394	CcSEcCtD
Propranolol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.00039	CcSEcCtD
Propranolol—Rash—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000387	CcSEcCtD
Propranolol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000387	CcSEcCtD
Propranolol—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.000365	CcSEcCtD
Propranolol—ADRB1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.69e-06	0.0018	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.68e-06	0.00178	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.67e-06	0.00178	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.67e-06	0.00177	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.67e-06	0.00177	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.66e-06	0.00176	CbGpPWpGaD
Propranolol—ADRB2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.66e-06	0.00176	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.64e-06	0.00174	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.64e-06	0.00174	CbGpPWpGaD
Propranolol—HTR1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.62e-06	0.00172	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.61e-06	0.00171	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.6e-06	0.0017	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.6e-06	0.0017	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.57e-06	0.00167	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.57e-06	0.00166	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.55e-06	0.00164	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.55e-06	0.00164	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.54e-06	0.00163	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.51e-06	0.0016	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	1.49e-06	0.00158	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.49e-06	0.00158	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	1.49e-06	0.00158	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.48e-06	0.00157	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.46e-06	0.00155	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	1.43e-06	0.00151	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	1.43e-06	0.00151	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.41e-06	0.00149	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.37e-06	0.00146	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.37e-06	0.00146	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	1.37e-06	0.00145	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.33e-06	0.00141	CbGpPWpGaD
Propranolol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.31e-06	0.00139	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.31e-06	0.00139	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.28e-06	0.00136	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.25e-06	0.00133	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.25e-06	0.00133	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.25e-06	0.00132	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.25e-06	0.00132	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.24e-06	0.00132	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.23e-06	0.0013	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.22e-06	0.0013	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.2e-06	0.00127	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.2e-06	0.00127	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.17e-06	0.00124	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.16e-06	0.00123	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.15e-06	0.00122	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.15e-06	0.00122	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.12e-06	0.00119	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.09e-06	0.00116	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.09e-06	0.00116	CbGpPWpGaD
Propranolol—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.08e-06	0.00115	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.08e-06	0.00114	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.07e-06	0.00114	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.06e-06	0.00112	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.05e-06	0.00111	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.03e-06	0.00109	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.02e-06	0.00109	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.02e-06	0.00108	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	1.02e-06	0.00108	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.94e-07	0.00105	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	9.93e-07	0.00105	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.9e-07	0.00105	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.89e-07	0.00105	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	9.75e-07	0.00103	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.72e-07	0.00103	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.68e-07	0.00103	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.57e-07	0.00101	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.56e-07	0.00101	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.5e-07	0.00101	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.47e-07	0.001	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.42e-07	0.000999	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	9.42e-07	0.000999	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	9.38e-07	0.000995	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.36e-07	0.000993	CbGpPWpGaD
Propranolol—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	9.25e-07	0.000981	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.15e-07	0.000971	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.14e-07	0.000969	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	9.02e-07	0.000957	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	9.01e-07	0.000955	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.97e-07	0.000951	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.94e-07	0.000948	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.74e-07	0.000927	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.69e-07	0.000921	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.65e-07	0.000917	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.62e-07	0.000914	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.55e-07	0.000907	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.5e-07	0.000901	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.47e-07	0.000898	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	8.32e-07	0.000882	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.31e-07	0.000881	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	8.12e-07	0.000861	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	7.98e-07	0.000846	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	7.79e-07	0.000826	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	7.68e-07	0.000814	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	7.65e-07	0.000812	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	7.62e-07	0.000808	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	7.61e-07	0.000807	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.58e-07	0.000804	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	7.5e-07	0.000795	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.45e-07	0.00079	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.37e-07	0.000782	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	7.34e-07	0.000778	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.27e-07	0.000771	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.26e-07	0.00077	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	7.17e-07	0.00076	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	7.16e-07	0.000759	CbGpPWpGaD
Propranolol—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	7.09e-07	0.000752	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	7.06e-07	0.000749	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.02e-07	0.000745	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.92e-07	0.000734	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.86e-07	0.000728	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.81e-07	0.000722	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.71e-07	0.000712	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.68e-07	0.000708	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.56e-07	0.000696	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	6.52e-07	0.000691	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	6.48e-07	0.000688	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.44e-07	0.000683	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	6.22e-07	0.000659	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	6.16e-07	0.000653	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.12e-07	0.000649	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.04e-07	0.00064	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.01e-07	0.000637	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	5.98e-07	0.000634	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.91e-07	0.000626	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.87e-07	0.000622	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	5.85e-07	0.00062	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	5.84e-07	0.000619	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.78e-07	0.000612	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.74e-07	0.000609	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	5.74e-07	0.000609	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	5.73e-07	0.000608	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.61e-07	0.000595	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.59e-07	0.000593	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	5.51e-07	0.000584	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.48e-07	0.000582	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.47e-07	0.00058	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.35e-07	0.000567	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.26e-07	0.000557	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	5.21e-07	0.000552	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	5.18e-07	0.000549	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.13e-07	0.000544	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	5.04e-07	0.000535	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.02e-07	0.000532	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	5e-07	0.000531	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.97e-07	0.000527	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	4.92e-07	0.000522	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.91e-07	0.000521	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	4.89e-07	0.000519	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	4.8e-07	0.000509	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.75e-07	0.000504	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	4.64e-07	0.000492	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.63e-07	0.000491	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	4.62e-07	0.00049	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.56e-07	0.000483	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.48e-07	0.000475	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.47e-07	0.000475	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.35e-07	0.000461	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.31e-07	0.000457	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	4.26e-07	0.000452	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	4.23e-07	0.000448	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	4.16e-07	0.000441	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	4.15e-07	0.00044	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.06e-07	0.000431	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	4e-07	0.000425	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	4e-07	0.000424	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.97e-07	0.000421	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.95e-07	0.000419	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	3.93e-07	0.000417	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.92e-07	0.000416	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	3.92e-07	0.000415	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	3.91e-07	0.000415	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.74e-07	0.000396	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	3.68e-07	0.000391	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.63e-07	0.000385	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.61e-07	0.000383	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.57e-07	0.000378	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.55e-07	0.000377	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.54e-07	0.000375	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.49e-07	0.00037	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.47e-07	0.000368	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.41e-07	0.000362	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.37e-07	0.000357	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.34e-07	0.000354	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	3.32e-07	0.000352	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	3.27e-07	0.000347	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.24e-07	0.000344	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.21e-07	0.000341	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	3.21e-07	0.00034	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	3.19e-07	0.000338	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.17e-07	0.000336	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	3.12e-07	0.000331	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.03e-07	0.000321	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	3.01e-07	0.000319	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.95e-07	0.000313	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.94e-07	0.000312	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.82e-07	0.000299	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.76e-07	0.000293	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.76e-07	0.000292	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.7e-07	0.000286	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.69e-07	0.000286	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.66e-07	0.000282	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.64e-07	0.00028	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.6e-07	0.000276	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.58e-07	0.000274	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.56e-07	0.000272	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.56e-07	0.000271	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.55e-07	0.00027	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.54e-07	0.000269	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.53e-07	0.000268	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.51e-07	0.000266	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.5e-07	0.000265	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.5e-07	0.000265	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.47e-07	0.000262	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.45e-07	0.00026	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.44e-07	0.000259	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.41e-07	0.000255	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.35e-07	0.000249	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.33e-07	0.000248	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.29e-07	0.000243	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.24e-07	0.000238	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.14e-07	0.000227	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.1e-07	0.000222	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.06e-07	0.000218	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.05e-07	0.000218	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2e-07	0.000212	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.97e-07	0.000209	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.97e-07	0.000208	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.95e-07	0.000207	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.93e-07	0.000205	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.91e-07	0.000203	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.74e-07	0.000184	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.64e-07	0.000174	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.6e-07	0.00017	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	1.58e-07	0.000167	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.58e-07	0.000167	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.57e-07	0.000166	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.57e-07	0.000166	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.53e-07	0.000163	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.5e-07	0.000159	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.39e-07	0.000147	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.36e-07	0.000144	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.33e-07	0.000141	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.14e-07	0.000121	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.08e-07	0.000114	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	8.82e-08	9.36e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	8.61e-08	9.13e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	8.12e-08	8.61e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	6.88e-08	7.29e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	5.31e-08	5.63e-05	CbGpPWpGaD
